Plus Therapeutics, Inc.
USD4.29
-0.00 (-0.00%)
CEO
Marc H. Hedrick
IPO Date
2001-07-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.31
Prev. Close
$4.29
Day Low
$4.20
Day High
$4.31
52W Low
$2.90
52W High
$23.50
Market Cap
$0.01B
Volume
0.02M
| -0.6 |
| 31 Dec 2023 | FY | -97.2% | -271.0% | 987.8% | -116.9% | -3.10 | 0.92 | -0.0 |
| 31 Dec 2022 | FY | -217.9% | -9051.3% | -314.6% | -84.9% | 0.89 | 1.84 | -0.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -123.7% | -61.0% | 0.65 | 3.36 | -0.0 |
| 31 Dec 2020 | FY | -791.1% | -2719.8% | -271.9% | -68.1% | 2.31 | 1.07 | -0.0 |
| 31 Dec 2019 | FY | 100.0% | -155.6% | -938.5% | -46.9% | 10.32 | 1.37 | -0.0 |
| 31 Dec 2018 | FY | 61.5% | -423.5% | -241.8% | -52.7% | 2.72 | 0.55 | -0.0 |
| 31 Dec 2017 | FY | 79.4% | -353.9% | -174.5% | -71.8% | 1.05 | 0.81 | -0.0 |
| 31 Dec 2016 | FY | 76.1% | -193.7% | -200.7% | -63.7% | 1.61 | 1.50 | -8.9 |
| -1.7 |
| 30 Sept 2025 | Q3 | 93.8% | -316.6% | -87.5% | -23.7% | 0.00 | 1.29 | -0.0 |
| 30 Jun 2025 | Q2 | 93.8% | 370.6% | 169.8% | 49.8% | 0.01 | 1.26 | 0.0 |
| 31 Mar 2025 | Q1 | 82.9% | -1643.2% | 73.6% | -144.3% | -0.00 | 1.03 | -0.0 |
| 31 Dec 2024 | Q4 | 83.6% | -276.4% | 43.6% | -58.8% | -0.38 | 0.34 | -0.0 |
| 30 Sept 2024 | Q3 | 84.1% | -197.4% | 55.5% | -41.2% | -0.66 | 0.44 | -0.0 |
| 30 Jun 2024 | Q2 | 84.2% | -229.9% | 38.6% | -26.2% | -0.45 | 0.50 | -0.0 |
| 31 Mar 2024 | Q1 | 88.9% | -194.5% | 67.4% | -58.0% | -0.78 | 0.41 | -0.0 |
| 31 Dec 2023 | Q4 | 86.1% | -290.2% | 282.6% | -33.5% | -3.10 | 0.92 | -0.0 |